70748-172 : Sevelamer Hydrochloride 400 mg Oral Tablet


NDC70748-172
Labeler: Lupin Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Sevelamer Hydrochloride
Dosage Form: Oral Tablet
Application #: ANDA213145
Rev. Date: 


NDC Package Codes:

  • 70748-172-27: 360 TABLET IN 1 BOTTLE (70748‑172‑27)

Active Ingredients:

  • Sevelamer Hydrochloride

Dosage Strength:

  • 400 mg

Pharmaceutical Classes:

  • Phosphate Binder [EPC]
  • Phosphate Chelating Activity [MoA]

Related Products:

Based on records with the same trade name.
  • 70748-173 Sevelamer Hydrochloride 800 mg Oral Tablet by Lupin Pharmaceuticals, Inc.
  • 0955-1048 Sevelamer Hydrochloride 800 mg Oral Tablet, Film Coated by Winthrop U.S.
  • 33342-241 Sevelamer Hydrochloride 400 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
  • 33342-242 Sevelamer Hydrochloride 800 mg Oral Tablet, Film Coated by Macleods Pharmaceuticals Limited
  • 59651-087 Sevelamer Hydrochloride 400 mg Oral Tablet, Film Coated by Aurobindo Pharma Limited
  • 59651-088 Sevelamer Hydrochloride 800 mg Oral Tablet, Film Coated by Aurobindo Pharma Limited
  • 60687-449 Sevelamer Hydrochloride 800 mg Oral Tablet, Film Coated by American Health Packaging
  • 68462-446 Sevelamer Hydrochloride 400 mg Oral Tablet, Film Coated by Glenmark Pharmaceuticals Inc., USA
  • 68462-447 Sevelamer Hydrochloride 800 mg Oral Tablet, Film Coated by Glenmark Pharmaceuticals Inc., USA
  • 72603-148 Sevelamer Hydrochloride 800 mg Oral Tablet, Film Coated by Northstar Rxllc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70748-172 QR Code

< Prev: 70748-153Next: 70748-173 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.